• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组纤溶酶原激活物抑制剂-1(rPAI-1)中的动态结构与功能关系

Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1).

作者信息

Vaughan D E, Declerck P J, Reilly T M, Park K, Collen D, Fasman G D

机构信息

Cardiology Division, West Roxbury VAMC, Boston, MA.

出版信息

Biochim Biophys Acta. 1993 Oct 6;1202(2):221-9. doi: 10.1016/0167-4838(93)90008-f.

DOI:10.1016/0167-4838(93)90008-f
PMID:8399383
Abstract

The conformational characteristics of active, latent, and denatured recombinant plasminogen activator inhibitor-1 (rPAI-1) were compared using UV spectroscopy, spectrofluorimetry and circular dichroism (CD) techniques. The UV absorbance wavelength maxima in all preparations approximated 280 nm, while the extinction coefficients of active and latent rPAI-1 differed by up to 60%. When incubated at 37 degrees C, the A280 of latent rPAI-1 was quite stable while the A280 of active rPAI-1 spontaneously increased, eventually approximating that of latent rPAI-1. Alkali difference spectroscopy yielded markedly divergent titration patterns for active and latent rPAI-1, suggesting that the tyrosine residues present in active and latent rPAI-1 differ in terms of solvent exposure. At an excitation wavelength of 280 nm, active rPAI-1 exhibited the greatest relative fluorescence quantum yield. The relative fluorescence of latent and denatured rPAI-1 were less than that of active PAI-1, and the emission maxima of both species were slightly red-shifted in comparison to that of active rPAI-1, suggesting that at least one of the four tryptophan residues present in rPAI-1 is less exposed to the aqueous environment in the active form of the molecule. In contrast, the derived secondary structures based on CD of active and latent rPAI-1 were nearly identical, with both moieties exhibiting approx. 40% alpha-helix and 15% beta-sheet. Taken together, these spectroscopic data provide evidence supporting the hypothesis that active and latent PAI-1 differ in terms of their tertiary conformation and aromatic residue exposure, while their secondary structures appear generally comparable. Furthermore, denaturant-induced reactivation of latent rPAI-1 produces a partially active rPAI-1 with spectroscopic properties similar to that of latent rPAI-1, suggesting that denatured rPAI-1 more closely resembles the latent rPAI-1 conformation after refolding. The spontaneous spectroscopic changes observed in rPAI-1 may reflect conformational transitions that are critical to the regulation of endogenous PAI-1 activity.

摘要

运用紫外光谱法、荧光光谱法和圆二色(CD)技术比较了活性、潜伏性和变性重组纤溶酶原激活物抑制剂-1(rPAI-1)的构象特征。所有制剂的紫外吸收波长最大值接近280nm,而活性和潜伏性rPAI-1的消光系数相差高达60%。在37℃孵育时,潜伏性rPAI-1的A280相当稳定,而活性rPAI-1的A280自发增加,最终接近潜伏性rPAI-1的A280。碱差光谱法得出活性和潜伏性rPAI-1的滴定模式明显不同,表明活性和潜伏性rPAI-1中存在的酪氨酸残基在溶剂暴露方面存在差异。在280nm的激发波长下,活性rPAI-1表现出最大的相对荧光量子产率。潜伏性和变性rPAI-1的相对荧光低于活性PAI-1,并且与活性rPAI-1相比,这两种物质的发射最大值都略有红移,表明rPAI-1中存在的四个色氨酸残基中至少有一个在分子的活性形式中较少暴露于水环境。相反,基于活性和潜伏性rPAI-1的CD推导的二级结构几乎相同,两者都表现出约4%的α-螺旋和15%的β-折叠。综上所述,这些光谱数据提供了证据支持以下假设:活性和潜伏性PAI-1在三级构象和芳香族残基暴露方面存在差异,而它们的二级结构总体上似乎具有可比性。此外,变性剂诱导的潜伏性rPAI-1再激活产生一种部分活性的rPAI-1,其光谱性质与潜伏性rPAI-1相似,表明变性rPAI-1在重折叠后更类似于潜伏性rPAI-1的构象。在rPAI-1中观察到的自发光谱变化可能反映了对内源性PAI-1活性调节至关重要的构象转变。

相似文献

1
Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1).重组纤溶酶原激活物抑制剂-1(rPAI-1)中的动态结构与功能关系
Biochim Biophys Acta. 1993 Oct 6;1202(2):221-9. doi: 10.1016/0167-4838(93)90008-f.
2
Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
Biochemistry. 1992 Oct 20;31(41):9877-82. doi: 10.1021/bi00156a004.
3
A spectroscopic study of the conformations of active and latent forms of recombinant plasminogen activator inhibitor-1.重组纤溶酶原激活物抑制剂-1活性和潜伏形式构象的光谱研究
Biochem Biophys Res Commun. 1991 Mar 15;175(2):437-43. doi: 10.1016/0006-291x(91)91583-x.
4
Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms.对活性、潜伏、底物和裂解形式的纤溶酶原激活物抑制剂(PAI-1)的构象研究。
Biochemistry. 1995 Jan 24;34(3):1064-9. doi: 10.1021/bi00003a042.
5
Conformational differences between latent and active plasminogen activator inhibitor, PAI-1: a spectroscopic study.潜伏型和活性纤溶酶原激活物抑制剂1(PAI-1)之间的构象差异:一项光谱学研究
Thromb Res. 1990 Sep 1;59(5):851-8. doi: 10.1016/0049-3848(90)90398-v.
6
Kinetically controlled folding of the serpin plasminogen activator inhibitor 1.丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂1的动力学控制折叠
Biochemistry. 1996 Dec 24;35(51):16443-8. doi: 10.1021/bi961214p.
7
Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.通过包涵体复性法纯化处于活性构象的重组纤溶酶原激活物抑制剂-1
Protein Expr Purif. 2003 Sep;31(1):99-107. doi: 10.1016/s1046-5928(03)00160-8.
8
Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.构建具有更高功能稳定性的纤溶酶原激活物抑制剂1突变体。
Biochemistry. 1994 Mar 29;33(12):3643-8. doi: 10.1021/bi00178a022.
9
Polymerization of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1的聚合反应。
J Biol Chem. 2001 Mar 23;276(12):9115-22. doi: 10.1074/jbc.M010631200. Epub 2000 Dec 1.
10
Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo.重新激活的重组纤溶酶原激活物抑制剂-1(rPAI-1)可有效防止体内溶栓。
Thromb Haemost. 1992 Jul 6;68(1):60-3.

引用本文的文献

1
Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.金属影响人纤溶酶原激活物抑制剂-1 的结构和活性。I. 稳定性和蛋白酶抑制的调节。
Protein Sci. 2011 Feb;20(2):353-65. doi: 10.1002/pro.568.
2
Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.纤溶酶原激活物抑制剂1:分子层面及临床意义
J Thromb Thrombolysis. 1995;2(3):187-193. doi: 10.1007/BF01062709.
3
Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.
纤溶酶原激活物抑制剂1分子中苯丙氨酸113至天冬氨酸138区域单个氨基酸取代的功能效应。
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):409-15. doi: 10.1042/bj3310409.